Skip to main content
Livermore
Livermore
ZHEN

Linden Advisors LP

SEC CIK
0001279396
Latest filing
Aug 14, 2026

The latest 13F from Linden Advisors LP covers Q2 2026 (filed Aug 14, 2026): 638 long positions worth $19.3B. The top 10 holdings make up 24.4% of the portfolio, and the largest is Vishay Intertechnology Inc at 4.3%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
165
Est. +$4.12B
Added
22
Est. +$45.6M
Reduced
16
Est. −$20.6M
Sold out
90
Est. −$2.62B

Top 5 holdings

Share of this quarter's portfolio value

  1. Vishay Intertechnology Inc928298AR9
    4.3%$829.5M
  2. MKS Inc55306NAB0
    3.1%$593.3M
  3. SITIME Corp82982TAA4
    3.1%$590.9M
  4. Guardant Health, Inc.40131MAD1
    2.7%$514.2M
  5. Centrus Energy Corp15643UAE4
    2.3%$444.5M

Biggest buys

New and added positions, by estimated amount bought

  1. SITIME Corp82982TAA4
    +$590.9MNew
  2. Super Micro Computer, Inc.86800UAF1
    +$250.9MNew
  3. Rubrik, Inc.781154AD1
    +$222.5MNew
  4. IREN Ltd46270CAD1
    +$218.3MNew
  5. Makemytrip Limited Mauritius56087FAD6
    +$215.4MNew

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SITIME Corp82982TAA4
    +3.06 pp0.0% → 3.1%
  2. Super Micro Computer, Inc.86800UAF1
    +1.30 pp0.0% → 1.3%
  3. Rubrik, Inc.781154AD1
    +1.15 pp0.0% → 1.2%
  4. IREN Ltd46270CAD1
    +1.13 pp0.0% → 1.1%
  5. Makemytrip Limited Mauritius56087FAD6
    +1.12 pp0.0% → 1.1%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Lumentum Hldgs Inc55024UAD1
    −$595.4MSold out
  2. BridgeBio Pharma, Inc.10806XAJ1
    −$225.4MSold out
  3. Ascendis Pharma A/S04351PAD3
    −$205.5MSold out
  4. Jazz Investments I Ltd472145AH4
    −$163.7MSold out
  5. CONMED Corp207410AH4
    −$135.2MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Lumentum Hldgs Inc55024UAD1
    −3.33 pp3.3% → 0.0%
  2. BridgeBio Pharma, Inc.10806XAJ1
    −1.26 pp1.3% → 0.0%
  3. Ascendis Pharma A/S04351PAD3
    −1.15 pp1.2% → 0.0%
  4. Jazz Investments I Ltd472145AH4
    −0.92 pp0.9% → 0.0%
  5. CONMED Corp207410AH4
    −0.76 pp0.8% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$19.3B
+$1.44B (+8.1%) vs. prior quarter
Positions
638
+75 vs. prior quarter
Top 10 concentration
24.4%
Top 10 as share of value
Turnover
14.2%
Q2 2026, one quarter
Average holding period
4.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $19.3B (Q2 2026)

Q1 2021: $13.5BQ2 2021: $18.9BQ3 2021: $17.0BQ4 2021: $16.3BQ1 2022: $15.9BQ2 2022: $10.9BQ3 2022: $10.9BQ4 2022: $9.51BQ1 2023: $9.50BQ2 2023: $9.53BQ3 2023: $9.75BQ4 2023: $10.5BQ1 2024: $12.6BQ2 2024: $12.0BQ3 2024: $11.9BQ4 2024: $12.1BQ1 2025: $14.7BQ2 2025: $16.3BQ3 2025: $15.0BQ4 2025: $16.2BQ1 2026: $17.9BQ2 2026: $19.3B
Q1 2021Q2 2026
13F filings of Linden Advisors LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026638$19.3BVishay Intertechnology IncMKS IncSITIME Corpvs. Q1 2026SEC
Q1 2026May 15, 2026563$17.9BLumentum Hldgs IncLumentum Hldgs IncLumentum Hldgs Incvs. Q4 2025SEC
Q4 2025Feb 17, 2026472$16.2BLumentum Hldgs IncCentrus Energy CorpLumentum Hldgs Incvs. Q3 2025SEC
Q3 2025Nov 14, 2025407$15.0BBloom Energy CorpBloom Energy CorpLumentum Hldgs Incvs. Q2 2025SEC
Q2 2025Aug 14, 2025376$16.3BStrategy IncCoinbase Global, Inc.Trip.com Group Ltdvs. Q1 2025SEC
Q1 2025May 15, 2025307$14.7BStrategy IncWestern Digital CorpSuper Micro Computer, Inc.vs. Q4 2024SEC
Q4 2024Feb 14, 2025264$12.1BMicroStrategy IncWestern Digital CorpConfluent, Inc.vs. Q3 2024SEC
Q3 2024Nov 14, 2024277$11.9BMicroStrategy IncINSMED IncConfluent, Inc.vs. Q2 2024SEC
Q2 2024Aug 14, 2024291$12.0BSea LtdSpotify USA IncConfluent, Inc.vs. Q1 2024SEC
Q1 2024May 15, 2024315$12.6BMicroStrategy IncSea LtdMongoDB, Inc.vs. Q4 2023SEC
Q4 2023Feb 14, 2024332$10.5BMongoDB, Inc.Li Auto Inc.Sea Ltdvs. Q3 2023SEC
Q3 2023Nov 14, 2023374$9.75BPinduoduo IncLi Auto Inc.Cree Incvs. Q2 2023SEC
Q2 2023Aug 14, 2023398$9.53BPalo Alto Networks IncCree IncPinduoduo Incvs. Q1 2023SEC
Q1 2023May 15, 2023467$9.50BCree IncPinduoduo IncBilibili Inc.vs. Q4 2022SEC
Q4 2022Feb 14, 2023572$9.51BCree IncPalo Alto Networks IncBilibili Inc.vs. Q3 2022SEC
Q3 2022Nov 14, 2022692$10.9BCree IncPalo Alto Networks IncSea Ltdvs. Q2 2022SEC
Q2 2022Aug 15, 2022724$10.9BPalo Alto Networks IncSea LtdCree Incvs. Q1 2022SEC
Q1 2022May 16, 2022721$15.9BPalo Alto Networks IncSea LtdCree Incvs. Q4 2021SEC
Q4 2021Feb 14, 2022720$16.3BSea LtdPalo Alto Networks IncCree Incvs. Q3 2021SEC
Q3 2021Nov 15, 2021631$17.0BSea LtdMongoDB, Inc.Bilibili Inc.vs. Q2 2021SEC
Q2 2021Aug 16, 2021821$18.9BBilibili Inc.Sea LtdBilibili Inc.vs. Q1 2021SEC
Q1 2021May 17, 2021710$13.5BSea LtdBilibili Inc.Snap Inc–SEC

13D and 13G filings

Companies where Linden Advisors LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Linden Advisors LP does not currently report owning 5% or more of any company.

Latest filings

55 filings on file made by Linden Advisors LP or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Linden Advisors LP
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
HYACHaymaker Acquisition Corp VSep 25, 202612:34 PM ETLinden Capital L.P.and 3 others13G6.10%1.75M sharesNewSep 22, 2026SEC
ONCH1RT Acquisition Corp.Mar 12, 202610:08 AM ETLinden Capital L.P.and 3 others13G5.90%1.01M sharesNewMar 5, 2026SEC
PALOUPaloma Acquisition Corp IMar 2, 20264:47 PM ETLinden Capital L.P.and 3 others13G5.20%800.0K sharesNewFeb 24, 2026SEC
AACIUArmada Acquisition Corp. IIIFeb 25, 20268:59 AM ETLinden Capital L.P.and 3 others13G5.50%1.40M sharesNewFeb 23, 2026SEC
AACOUAbony Acquisition Corp. IFeb 23, 20267:57 PM ETLinden Capital L.P.and 3 others13G5.70%1.35M sharesNewFeb 20, 2026SEC
PAACUProem Acquisition Corp. IFeb 18, 20264:17 PM ETLinden Capital L.P.and 3 others13G7.50%1.00M sharesNewFeb 17, 2026SEC
KTWOUK2 Capital Acquisition CorpFeb 17, 20262:09 PM ETLinden Capital L.P.and 3 others13G5.30%750.0K sharesNewFeb 9, 2026SEC
RNGTRange Capital Acquisition Corp IIFeb 12, 20262:11 PM ETLinden Capital L.P.and 3 others13G/A7.30%1.73M shares+2.20 ppfrom 5.10%Dec 31, 2025SEC
IPEXInflection Point Acquisition Corp. VFeb 12, 20262:10 PM ETLinden Capital L.P.and 3 others13G/A8.00%875.7K shares+1.30 ppfrom 6.70%Dec 31, 2025SEC
HVIIONE Nuclear Energy Inc.Feb 12, 20262:08 PM ETLinden Capital L.P.and 3 others13G/A7.40%1.46M shares–Dec 31, 2025SEC
LPSNLiveperson IncFeb 12, 20262:06 PM ETLinden Capital L.P.and 3 others13G/A0.00%5.00K shares–Below 5%Dec 31, 2025SEC
HGASGlobal Gas CorpFeb 12, 20262:04 PM ETLinden Capital L.P.and 3 others13G/A4.60%358.1K shares–Below 5%Dec 31, 2025SEC
FGIIUFG Imperii Acquisition Corp.Jan 30, 202611:28 AM ETLinden Capital L.P.and 3 others13G6.60%1.50M sharesNewJan 23, 2026SEC
XCBEUX3 Acquisition Corp. Ltd.Jan 26, 20269:01 PM ETLinden Capital L.P.and 3 others13G7.00%1.40M sharesNewJan 22, 2026SEC
BCARD. Boral ARC Acquisition I Corp.Jan 26, 20268:54 PM ETLinden Capital L.P.and 3 others13G5.50%1.60M sharesNewJan 21, 2026SEC
ZKPULafayette Digital Acquisition Corp. IJan 16, 20261:56 PM ETLinden Capital L.P.and 3 others13G6.10%1.80M sharesNewJan 13, 2026SEC
Bleichroeder Acquisition Corp. IIClass A ordinary shares, par value $0.0001 per shareJan 13, 20264:06 PM ETLinden Capital L.P.and 3 others13G5.20%1.50M sharesNewJan 9, 2026SEC
SORNUSoren Acquisition Corp.Jan 13, 20264:05 PM ETLinden Capital L.P.and 3 others13G6.30%1.60M sharesNewJan 9, 2026SEC
ARTCUArt Technology Acquisition Corp.Jan 12, 20267:50 AM ETLinden Capital L.P.and 3 others13G7.00%1.60M sharesNewJan 8, 2026SEC
EVOXEvolution Global Acquisition CorpDec 23, 20255:58 PM ETLinden Capital L.P.and 3 others13G5.00%1.20M sharesNewDec 22, 2025SEC